Objective: Matrix metalloproteinase-9 (MMP-9) activity is up regulated in the heart subjected to ischemic insult. Whether increased MMP-9 activity contributes to acute myocardial injury after ischemia-reperfusion remains unknown. To investigate the role of MMP-9 in myocardial infarction, we utilized a MMP-9 knockout mouse. Methods and results: Standard homologous recombination in embryonic stem cells was used to generate a mouse lacking MMP-9. The left anterior descending coronary artery was occluded for 30 min followed by 24 h reperfusion, and the ischemic and infarct sizes were determined. Targeted deletion of MMP-9 protected the heart from no-flow ischemia-reperfusion-induced myocardial injury. The myocardial infarct size was reduced by 17.5% in MMP-9 heterozygotes (1 / 2) (P,0.01) and 35.4% in MMP-9 knockout (2 / 2) mice (P,0.01) versus the wild-type (1 / 1) mice, respectively. Analysis of MMP activity in myocardial extracts by zymography demonstrated that ischemia-reperfusion-induced expression of proMMP-9 and active MMP-9 was reduced by 77.8% (P,0.01) and 69.1% (P,0.001), respectively, in (1 / 2) mice compared to (1 / 1) mice, and was absent in (2 / 2) animals. The expression of TIMP-1, an endogenous inhibitor of MMP-9, was elevated 4.7-fold (P,0.05) and 21.4-fold (P,0.05) in the (1 / 2) and (2 / 2) mice, respectively, compared to (1 / 1) mice. Immunohistochemical analysis revealed that neutrophils were the primary cellular source of MMP-9, and less neutrophils were detected in the ischemic region of the heart following ischemia-reperfusion in (2 / 2) mice compared to (1 / 1) mice. Measurement of myeloperoxidase activity, a marker enzyme of neutrophils, demonstrated a 44% reduction in neutrophils infiltrated into the ischemic myocardium in the (2 / 2) mice compared to the (1 / 1) mice (P,0.05). Conclusion: These results suggest that MMP-9 plays an important role in ischemia-reperfusion-induced myocardial infarction and MMP-9 could be a target for prevention or treatment of acute ischemic myocardial injury.
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Matrix metalloproteinases (MMPs) are a family of structurally related, zinc-containing enzymes that degrade *Corresponding author. Tel.: 11-610-270-4841; fax: 11-610-270-various components of the extracellular matrix [1, 2] . 5080 .
Increased expression and activity of MMPs have been
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identified in various pathological processes such as inflam-
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mation, tumor metastasis and ischemic injury. However, on potential avenues for pharmacological approaches to the the correlation of particular MMPs with specific diseases treatment of ischemic heart diseases and failure. remains a key question.
The present study was undertaken in an established MMP-9 is one of the MMPs expressed in the heart. mouse myocardial infarction model [10] to evaluate the Increased myocardial MMP-9 expression or activity has influence of targeted deletion of MMP-9 on acute myocarbeen found in a variety of experimental myocardial injuries dial injury induced by no-flow ischemia-reperfusion in such as the permanent coronary artery occlusion model in MMP-9-knockout (2 / 2) mice compared to the heterorat and rabbit [3, 4] , and the reperfusion injury model in zygous (1 / 2) littermates and wild-type (1 / 1) mice. porcine [5, 6] . Up regulation of MMP-9 has also been demonstrated in failing human heart, indicating a possible role of MMP-9 in cardiomyopathy [7, 8] . A recent chronic 2. Methods study in mice showed that targeted deletion of MMP-9 attenuated permanent coronary artery ligation-induced left 2.1. Targeting of MMP-9 gene and generation of mutant ventricle enlargement and collagen accumulation, suggestmice ing that MMP-9 plays a prominent role in cardiac remodeling after ischemic injury [9] . However, whether increased
Gene targeting was performed in E14.1 ES cells by MMP-9 activity contributes to acute myocardial injury standard procedures [11] , replacing exons 1-12 of the (infarction) following ischemia-reperfusion remains unmouse MMP-9 locus (Accession X72794) with a positive explored. Such information will have a significant impact selection cassette containing the neomycin phosphotransboth on the understanding of the basic biology of extracelferase gene driven by the PGK promoter (Fig. 1A) . lular matrix turnover in acute myocardial injury, as well as Homology arms of 4.5 kb (59) and 5.5 kb (39) were cloned (Fig. 1B) . Approximately 1 in detected by triphenyltetrazolium staining, quantified by 100 G418-resistant clones had undergone homologous computerized videoplanimetry and expressed as a perrecombination. Three targeted clones were injected into centage of ischemic area as described previously [10] . C57B16 / J-derived blastocysts. Male chimeras were crossed with C57B16 / J females to give N1F0 offspring, 2.3. Measurement of MMPs by zymography which were subsequently inter-crossed to generate N1F1 offspring. Genotyping of N1F0 and N1F1 offspring was
The whole heart was excised from the MMP-9 (1 / 1), confirmed by the above Southern blot procedure. In (1 / 2) and (2 / 2) mice subjected to ischemia-reperfusion addition, N1F0 offspring were successively back-crossed or from sham-operated animals (n54-7 per group and to C57B16 / J females to generate N5FO mice. These were time point) and the vasculature, right ventricle free wall inter-crossed to create an N5F1 study population. Genoand atrial appendages were dissected away. The remaining type analysis of mice during back-crossing and for the left ventricle free wall was washed with cold PBS, snap generation of the N5F1 study population was performed by frozen in liquid nitrogen, and stored at 280 8C. Compar-PCR of tail DNA (Fig. 1C ). Primers were designed to able samples were collected from sham-operated animals. generate PCR products specific to the wild-type locus 3 For extraction, tissues were minced into 1-mm pieces and (E12, 59 primer exon 12 specific: 59-TCATCGCTTGTCCincubated with 0.5% Triton X-100 (Sigma) in PBS con-ACCTTCCTG-39; E13a and E13b, 39 primers exon 13 taining 0.01% sodium azide while gently rotating at 4 8C specific:
59-TGCCATGGCAGAAATAGGCTTTGTCTfor 18 h. The concentration of the extraction mixture for AC-39 or 59-CACTGCAGGAGGTCGTAGGTCACGTeach sample was normalized to 400 mg / ml. After the AG-39, giving product sizes of 1282 and 1394 bp, respecextraction was complete, the samples were centrifuged at tively) or targeted locus (N59-1, neo gene specific 59 14 000 rpm (10 min, 4 8C) and the supernatants were primer: 59-TGAACAAGATGGATTGCACGCAGGTTCTcollected. Protein concentration for each sample was CCGGC-39 and N39-1, neo gene specific 39 primer: 59-GCdetermined with the BioRad DC Protein Assay kit. CAAGCTCTTCAGCAATATCACGGGTAGC-39 giving a MMP enzyme expression was analyzed for gelatinolytic product of 800 bp; or N59-2, neo gene specific 59 primer:
activity by SDS-PAGE zymography as described previ-59-GCCATTATGGGATCGGCCATTGAACAAGATG-39 ously [4] . Briefly, samples (100 mg) were subjected to and N39-2, neo gene specific 39 primer: 59-GCGAATCGGelectrophoresis, without boiling or reduction, through a GAGCGCGATACCGTAAAGCA-39 giving a product of 10% polyacrylamide gel with 0.1% gelatin incorporated as 700 bp). Thirty cycles of 94 8C (30s), 60 8C (30s), and a substrate (Novex). After electrophoresis, the gel was 72 8C (90s) were used. The investigation conforms with incubated in renaturing buffer (Novex) (30 min, 25 8C), the Guide for the Care and Use of Laboratory Animals equilibrated in developing buffer (Novex) (30 min, 25 8C), published by the US National Institutes of Health (NIH and then incubated in fresh developing buffer (Novex) (18 Publication No. 85-23, revised 1996. All experiments were h, 378). Gels were fixed with 40% methanol-7% acetic conducted according to the requirements of the United acid, stained with 0.25% Coomassie brilliant blue R250 Kingdom Animals (Scientific Procedures) Act (1986) and and then destained with 10% methanol-7% acetic acid. strictly conformed to the ethical standards of GlaxoSEnzyme activity attributed to MMP-9 and MMP-2 was mithKline Pharmaceuticals.
visualized as clear bands against a blue background. Standards (3 ng) of recombinant human MMP-9 and 2.2. Myocardial ischemia and reperfusion protocol MMP-2 (Chemicon) were included on the gels for comparison and identification. Relative clearing of each sample Male MMP-9 (1 / 1), (1 / 2) and (2 / 2) mice, ranging was quantitated by determining the inverse optical density in age from 8 to 10 weeks, underwent myocardial isunits using a Kodak Image Station 440CF (NEN). Values chemia-reperfusion as described in detail previously [10] .
are represented as the mean6standard error and are Briefly, the animals were anesthetized with pentobarbital presented as inverse optical density units relative to sodium (60 mg / kg) and ventilated with a rodent ventilator.
background. The electrocardiogram (ECG) and the body temperature of the mice were monitored throughout the experiment. Coronary artery occlusion (30 min) and reperfusion (24 h 2.4. Western blot analysis for MMP-9 and TIMP-1 unless otherwise indicated) were induced by inflating and then deflating a nontraumatic balloon occluder that was Samples (100 mg, n54-7 per group) were resolved by electrophoresis through a 10 or a 12% polyacrylamide gel under reducing conditions and then transferred to a nitrocellulose membrane for MMP-9 and TIMP-1 analysis, respectively. After blocking overnight at 4 8C with 5% nonfat powdered milk in 1.5 M NaCl, 0.5% Triton X-100, 0.1 M Tris-HCl, pH 8.0 (TBST buffer), the blot was incubated with a rabbit anti-MMP-9 (0.4 mg / ml, [AB19047, Chemicon) or mouse anti-TIMP-1 antibody (1 mg / ml, [IM32L, Oncogene Research), washed with TBST and then incubated with a goat anti-rabbit or mouse IgG secondary antibody conjugated to horseradish peroxidase (1:5000; Gibco-BRL). The blot was developed using the enhanced chemiluminescence method (Amersham) according to the manufacturer's instructions. Relative levels of TIMP-1 expression were quantitated by determining the optical density units of each band using a Kodak Image Station 440CF (NEN).
Immunohistochemical analysis
Immunohistochemical staining for MMP-9 was performed using a rabbit anti-mouse MMP-9 polyclonal primary antibody (0.7 mg / ml, Chemicon). Prior to this, antigen retrieval was performed by incubating the tissue sections with proteinase K (Dako) for 3 min at room temperature. Immunohistochemical staining for neutrophils was performed using an adsorbed rabbit anti-mouse PMN polyclonal primary antibody (0.75 mg / ml, Inter-Cell Technologies). As a negative control, serial sections were incubated with rabbit IgG (0.7 mg / ml, Vector). For macrophage analysis, a rat anti-murine pan macrophage antibody ([T-2006, 1:100, BMA) and rat IgG (2 mg / ml, Sigma), as a negative control, were used. The sections were then incubated with a biotinylated goat anti-rabbit IgG secondary antibody. Additional sections were also stained with hematoxylin and eosin (H&E) using standard histological methods.
Measurement of myeloperoxidase (MPO) activity in cardiac tissue
MPO activity, an enzyme that is specific for neutrophils, was determined in ischemic cardiac tissue by the method of Bradley et al. [12] as described previously [13] , and was 
Statistical analysis
Data are expressed as mean6S.E.M. and analyzed by one-way ANOVA with subsequent post hoc paired comparison (Bonferroni) or by unpaired student's t-test. Differences with a value of P,0.05 were considered statistically significant. Fig. 2A,B show the time-course of MMP-9 protein expression following myocardial ischemia-reperfusion in the MMP-9 (1 / 1) mice (n54-7 per time point). Significant expression of proMMP-9 and active MMP-9 was detected after 30 min of ischemia and further up regulated following reperfusion. MMP-9 expression was absent in the sham (basal) control samples. ProMMP-2 was detected in all samples and was elevated significantly at 4 and 24 h after reperfusion ( Fig. 2A,C) . As shown in Fig. 3A , the expression of proMMP-9 and active MMP-9 was markedly attenuated (reduced 77.866.6% (P,0.01) and 69.167.2% (P,0.001), respectively) in (1 / 2) mice compared to (1 / 1) mice, and was absent in (2 / 2) mice in samples collected after 24 h of reperfusion (n54-7 per group). The expression profile of MMP-9 in the three groups of mice was also confirmed by Western blot (Fig. 3B) . Expression of proMMP-2 was comparable in the three groups of mice mice subjected to 30 min of ischemia followed by 24 h of reperfusion. Molecular weight markers are as indicated. (B) Densitometric analysis of TIMP-1 levels in (1 / 2) and (2 / 2) mice, relative to (1 / 1) mice. Animals were subjected to 30 min of ischemia followed by 24 h of reperfusion (n54-7 per group). *P,0.05 versus (1 / 1) mice and each other. (Fig. 3A) . It should be noted, though, that an intermediate between pro and active MMP-2 was also observed in the (1 / 1) mice. Further, TIMP-1, an endogenous MMP-9 inhibitor, was shown to be expressed in MMP-9 (1 / 1) mice after ischemia-reperfusion and was up-regulated (4.762.0-fold, P,0.05) in (1 / 2) and (21.465.8-fold, P,0.05) in (2 / 2) mice (Fig. 4A,B) . (30-min ischemia and up to 24-h reperfusion), but macro-(1 / 1), (1 / 2) and (2 / 2) mice subjected to 30 min of ischemia phages were not detected during this acute phase of (data followed by 24 h of reperfusion (n54-7 per group). Molecular weight markers are as indicated. not shown). 
Results

Expression of MMP-9, MMP-2 and TIMP-1 in myocardium subjected to ischemia-reperfusion
Neutrophils express MMP-9 in ischemic myocardium
Targeted deletion of MMP-9 protects myocardium
following ischemia-reperfusion (24 h) in (2 / 2) mice from ischemia-reperfusion injury compared to (1 / 1) mice (Fig. 7A) . Specific quantitation of neutrophil infiltration was performed by biochemical As shown in Fig. 6A left side, all three groups of mice analysis of MPO expression, a marker for neutrophils. The displayed a similar-sized ischemic area, indicating that a results demonstrated that MPO activity in the ischemic comparable degree of ischemic jeopardy existed in (1 / 1), myocardium from (2 / 2) mice was reduced by 44% (P, (1 / 2) and (2 / 2) mice. However, the myocardial infarct 0.05; n58) compared to that from (1 / 1) mice (n57), size (percent of ischemic area) was reduced from 65.361. 6 further indicating a significant reduction in neutrophils in the (1 / 1) group (n510) to 53.962.1 in the (1 / 2) infiltrated into myocardium subjected to ischemia-reperfugroup (17.5% reduction, n59, P,0.01). The myocardial sion (Fig. 7B) . The basal level of MPO activity was very infarct size was further decreased in (2 / 2) group to low in the non-ischemic myocardium in both (2 / 2) and 42.262.8 (35.4% reduction, n58, P,0.01 versus both the (1 / 1) groups (data not shown). (1 / 1) and (1 / 2) group) (Fig. 6A, right side, and B) .
Targeted deletion of MMP-9 reduces neutrophil
Discussion infiltration in the heart after ischemia-reperfusion injury
Several recent studies which focused on chronic cardiac Immunohistochemical analysis for neutrophils indicated remodeling have demonstrated that MMP activation might less neutrophils in the ischemic region of the heart contribute to the changes in left ventricular geometry and dysfunction that occur with the progression of dilated and (2 / 2) mice may also be due, in part, to the elevated myopathy [14] [15] [16] . However, which MMP plays a role expression of TIMP-1 in addition to the lack of MMP-9. In was not clear as broad-spectrum MMP inhibitors were diseases where matrix degradation and inflammatory cell used in these studies. In a mouse heart failure model, influx occur, the balance between MMPs and TIMPs is Ducharme et al. [9] reported that deletion of MMP-9 often offset resulting in an overall net increase in MMP decreased end-systolic and -diastolic ventricular dimenactivity. Changes in MMP expression and the imbalance sions at 1-2 week after permanent ligation of coronary between proteinases and proteinase inhibitors have been artery, suggesting a role for MMP-9 in chronic cardiac noted in cardiovascular diseases including ischemic carremodeling. However, the role of MMP-9 in acute myocardiomyopathy [18], cardiac dilation and heart failure dial injury is still unknown. The present study, using [7, 19, 20] , acute coronary syndromes [21] , and cardiac targeted gene deletion, has demonstrated that MMP-9 rupture after acute myocardial infarction [22] . Of imporplays an important role in ischemia-reperfusion-induced tance, in the (2 / 2) mice the balance is offset in favor of myocardial infarction. To our knowledge, this is the first proteolytic inhibition, thus contributing to the positive study that demonstrates the pivotal role of MMP-9 in acute effect observed. Notably, our study was designed to myocardial injury.
investigate the role of MMP-9 in the acute phase of As shown in Fig. 6 , there was no difference in ischemic myocardial ischemia and reperfusion. Indeed, targeted area, expressed as percent of left ventricle, among the three deletion of MMP-9 and the up-regulation of TIMP-1 groups of mice, indicating that the animals in the three resulted in reduced infarct size when analyzed 24 h groups received a comparable degree of ischemic jeopardy.
following ischemic injury. Similarly, others have demonTherefore, the significant reduction of infarct size in the strated that targeted deletion of MMP-9 and up regulated (2 / 2) and (1 / 2) mice compared with the (1 / 1) mice TIMP-1 are also beneficial in chronic myocardial injury was due to the targeted deletion of MMP-9. This conclu- [9] . Conversely, expression of other MMPs such as MMPsion was further supported by the fact that MMP-9 2 have been shown to be important in myocardial healing expression levels correlated with the myocardial infarct that occurs in the later phases after injury [9, 22] . size among the three groups of mice (Fig. 6) . The results
In conclusion, our results suggest that MMP-9 plays an clearly indicate that deficiency of MMP-9 provides a important role in ischemia-reperfusion-induced acute protective effect against ischemia-reperfusion-induced myocardial infarction. Attenuation of neutrophil activity myocardial infarction.
and proteolytic-mediated tissue damage by targeted deleExpression of MMP-9 in the heart has been demontion of MMP-9 could contribute to this protection. MMP-9 strated in previous studies [5] [6] [7] [8] . However, the cellular may be a target for prevention or treatment of acute source of MMP-9 in the heart is not clear. Our study has ischemic myocardial injury. demonstrated that infiltrating neutrophils are the major source of MMP-9 in the reperfusion-injured heart (Figs. 5 and 7). Our data are in accordance with a recent study References published while this manuscript was in preparation [17] . The study, conducted in canine, indicated neutrophils as
